NCT02309827View on ClinicalTrials.gov

Safety and Pharmacokinetic Study of PF-06651600 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Healthy
Interventions
DRUG

PF-06651600 or Placebo

PF-06651600 or placebo will be administered as an extemporaneously prepared solution in each cohort.

Trial Locations (1)

B-1070

Pfizer Clinical Research Unit, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02309827 - Safety and Pharmacokinetic Study of PF-06651600 in Healthy Volunteers | Biotech Hunter | Biotech Hunter